Summary
This study, conducted by several Japanese research departments, aimed to evaluate the efficacy and safety of high-dose taurine supplementation to prevent stroke-like events resulting from a genetic disorder. Therefore, 10 patients received a high-dosed taurine supplement for 52 weeks. 80% of the patients who were administered with taurine showed a reduced frequency of stroke-like events. No severe adverse side effects were observed. This study demonstrated that oral high-dose taurine supplementation could effectively reduce the recurrence of stroke-like events. More details can be found in the study.
References
Ohsawa et al.